LiveCare Inc.(OTCMKTS: LVCE) Enters Hypertension Market, Enhancing Healthcare Monitoring for U.S. Adults
February 28, 2024 09:00 ET
|
LiveCare Inc.
Venice, FL, USA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a leading innovator in healthcare solutions, proudly announces the launch of a state-of-the-art blood pressure cuff...
Pulmonary Arterial Hypertension Market is estimated to be US$ 12.2 billion by 2032 and is anticipated to register a CAGR of 5.5%. – By PMI
October 18, 2023 08:30 ET
|
PMI
Covina, Oct. 18, 2023 (GLOBE NEWSWIRE) -- How is PAH diagnosed? Pulmonary Arterial Hypertension (PAH) is the form of broader condition called as pulmonary hypertension, where the...
Global Pulmonary Arterial Hypertension Market Report 2023: Growing Prevalence of Lung Cancer and Other Lung Related Disorders Drives Sector
May 31, 2023 07:23 ET
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and...
Worldwide Pulmonary Arterial Hypertension (PAH) Equipment Industry Report to 2028
February 04, 2022 06:43 ET
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (PAH) Equipment" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering. ...
Insights on the Pulmonary Arterial Hypertension Global Market to 2027 - Advanced Oral Drugs for Pulmonary Arterial Hypertension Presents Opportunities
January 26, 2022 06:13 ET
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2021-2027) by Drug Class, Route of Administration, Distribution Mode, and Geography, IGR Competitive Analysis,...
Worldwide Diltiazem Industry to 2028 - Increase in Cardiovascular Disease Incidence is Driving Growth
October 21, 2021 06:58 ET
|
Research and Markets
Dublin, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Capsules, Injection, and Tablets); Application (Angina,...
Hypertension: 2021 Comprehensive Industry Assessment
October 01, 2021 09:53 ET
|
Research and Markets
Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Hypertension Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
Worldwide Pulmonary Arterial Hypertension Industry to 2026 - Advance Oral Drugs for Pulmonary Arterial Hypertension Present Opportunities
July 05, 2021 04:28 ET
|
Research and Markets
Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension Market (2021-2026) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis...
Global Pulmonary Arterial Hypertension Market Report 2021: Market Leaders Opsumit and Uptravi are Being Investigated in Clinical Trials to Potentially Support Label Expansions to CTEPH
June 09, 2021 08:58 ET
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension Market and Forecast Analysis to 2025" drug pipelines has been added to ResearchAndMarkets.com's offering. The report...
Worldwide Pulmonary Arterial Hypertension Industry to 2025 - Featuring Gilead Sciences, United Therapeutics and Novartis International Among Others
January 20, 2021 06:33 ET
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2020-2025) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis and the...